CORRECTING and REPLACING GC Pharma Receives Complete Response Letter From the U.S. FDA For ‘GC5107’
YONGIN, South Korea--(BUSINESS WIRE)--Please replace the release dated 27 February, 2022, with the following corrected version due to multiple revisions....











